unknown
Stage
About
FluidForm develops a proprietary 3D bioprinting platform called FRESH to create implantable, vascularized tissues aimed at treating diseases like type 1 diabetes with minimally invasive, implantable solutions.
Explore FluidForm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.